Abstract
Several N-acyl phenothiazine chalcones were prepared by the condensation of various aldehydes with N-acyl phenothiazine in alcoholic KOH. The chalcones were further treated with urea and thiourea to obtain 6-(substituted phenyl)-4-(10H-phenothiazin-10-yl)pyrimidin-2(1H)-ones/thiones. All the synthesized compounds were screened for their antimicrobial activity and characterized by elemental analyses, IR, 1H NMR, and mass spectroscopy.
Similar content being viewed by others
References
J. A. Eussell, Annu. Rev. Biochem., 14, 309 (1945).
R. A. Cox, Quart. Rev., 22, 499 (1968).
R. A. Cox, Quart. Rev., 22, 934 (1968).
P. Callery and P. Gannett, Cancer and Cancer Chemotherapy, in Foye’s Principles of Medicinal Chemistry, D. A. Williams and T. L. Lemke (eds.), Lippincott Williams and Wilkins, Philadelphia (2002).
O. N. Al Safarjalani, X. J. Zhou, R. H. Ras, et al., Cancer Chemother. Pharmacol, 55, 541 (2005).
W. A. Remers, Antineoplastic Agents, in Wilson and Gisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry, J. N. Delgado and W. A. Remers (eds.), Lippincott Williams and Wilkins, Philadelphia (1998).
G. B. Elion, Fed. Proc., 26, 898 (1967).
J. H. Burchenal, Blood, 8, 965 (1953).
B. D. Clarkson, Cancer, 5, 227 (1970).
S. A. Giller, R. A Zhuk, and M. I. Lidak., Dokl. Akad. Nauk. SSSR, 176, 332 (1967).
J. C. Shishoo, S. U. Pathak, S. I. Rathod, and S. K. Jain., Indian J. Chem. 38B, 684 (1999).
M. K. El-Said, Pharmazie, 36, 678 (1981).
R. Tilak, R.Tyagi, B. Goel, K. K. Saxena, V. K. Srivastava, and A. Kumar, Indian Drugs, 35, 216 (1998).
J. N. Dominguez, S. Lopez, J. Charris, et al., J. Med. Chem., 40, 2726 (1997).
G. Lin, K. K. Midha, and E. M. Hawes., J. Heterocycl. Chem., 28, 215 (1991).
T. N. Bansode, J. V. Shelke, and V. G. Dongre., Eur. J. Med. Chem., 44, 5094 (2009).
T. N. Bansode, P. M. Dongre, and V. G. Dongre., Pharm. Chem. J. 43, 311 (2009).
M. Viveros, and L. Amaral., Int. J. Antimicrob. Agents, 17, 225 (2001).
L. Amaral, and J.E. Kristiansen., Int. J. Antimicrob. Agents, 14, 173 (2000).
A. Trivedi, A. Siddiqui, V. Shah, ARKIVOC, (ii), 210 (2008).
N. Motohashi, M. Kawase, S. Saito, and H. Sakagami, Curr. Drug Targets, 1, 237 (2000).
N. Motohashi, T. Kurihara, K. Satoh, et al., J. Anticancer Res., 19, 1837 (1999).
T. Kurihara , N. Motohashi, G. Pang, M. Higno, and K. Kiguchi, J. Anticancer Res., 16, 2757 (1996).
D. Ledincer, and L. A. Mitscher, Org. Chem. Drug. Syn., 1, 372 (1976).
A. A. Borbely, and M. Loepfe-Hinkkanen., Mod. Phamacol.Toxicol., 16, 403 (1979).
A. Jurasek, V. Knoppava, M. Dandarova, and A. Kovac, J. Reinprecht, Tetrahedron 34, 1883 (1978).
G. V. Subbraju, A. RangaNayakulu, and D. Parameshwara., Indian J. Heterocyclic Chem. 4, 87 (1994).
B. A. Bhat, K. L. Dhar, S. C. Puri, et al., Bioorg. Med. Chem. Lett. 15, 3177 (2005).
J. N. Domínguez, C. J. Rodrigues, N. Gamboa de Domínguez, et al., Farmaco, 60, 307 (2005).
N. Yaulì, O. Üçüncü, E. Aydìn, et al., J. Photochem. Photobiol. A: Chem., 169, 229 (2005).
S. Khatib, O. Narya, R Musa, et al., Bioorg. Med. Chem., 13, 433 (2005).
Indian Pharmacopoeia. (New Delhi, India) (1996).
R. Ananthnarayan, and J. Paniker, Textbook of Microbiology, 5th Edition, Orient Longman, Madras (1997).
A. L. Barry, The Antimicrobic Susceptibility Test: Principles & Practices, Lea & Febiger, Philadelphia, PA (1976); Biol. Abstr., 64 (1976).
G. S. Kobayashi and G. M. Medofff, Ann. Rev. Microbiol., 31 291 (1977).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bansode, T.N., Rangari, R.P. & Shimpi, P.A. Synthesis and Biological Evaluation of Some Novel 6-(Substituted Phenyl)-4-(10H-Phenothiazin-10-YL)Pyrimidin-2(1H)-Ones/Thiones. Pharm Chem J 48, 430–433 (2014). https://doi.org/10.1007/s11094-014-1125-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-014-1125-4